Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
6/5/2025
Mainland Chinese Market for Weight Loss and Diabetes Drugs to Soon Be ...
6/4/2025
China's Child Health Improves: NHC Official
5/31/2025
China's Breakthru Weight-Loss Drug Makes Landmark Debut in NEJM
5/29/2025
CDE Issues Guideline on Safety Assessment and Reporting in Pediatric D...
5/29/2025
CDE Launches “Starlight Plan” to Encourage Pediatric Antitumor Drug ...
5/20/2025
'China's Ozempic' may vie with Eli Lilly, Novo Nordisk for global weig...
5/8/2025
Dementia Cases Surge in China at an Unprecedented Rate
5/7/2025
Novo Nordisk Sees Surge in China on Wegovy Launch, GLP-1 Momentum
4/29/2025
China NMPA Suspends Digoxin API Imports from VITAL LABS
4/17/2025
This Pharma Company Is Betting Big On A Chinese Ozempic Rival (Forbes)
4/15/2025
China NMPA Approves Kowa's Parmodia (Pemafibrate) for Dyslipidemia Tre...
4/15/2025
U.S. Tariff Threat on Chinese Pharma Could Reshape Landscape for India...
3/31/2025
Hengrui Medicine Expands Phase 3 Trials for Oral GLP-1R Agonist HRS-75...
3/25/2025
Novo Nordisk and the United Labs Announce License Deal for UBT251
3/25/2025
BrightGene Initiates Phase II Head-to-Head Study of AI-Designed BGM050...
3/21/2025
Rhythm Pharma Regains Rights to Obesity Drug in China
3/17/2025
Innovent Launches GLORY-3: A Phase 3 Head-to-Head Study of Mazdutide v...
3/12/2025
Eli Lilly Plans Late 2025 Launch of Weight Loss Drugs in China and Ind...
3/4/2025
HighTide Thera Publishes Positive Phase 2 Data on HTD1801 for Type 2 D...
2/28/2025
CDE Seeks Public Feedback on "SPARK Initiative" to Boost Pediatric Onc...
2/21/2025
India Can Surpass China in Drug Discovery, Says Biocon Chief
2/19/2025
CSPC Pharma Partners with Radiance for Global Development of Anticance...
2/18/2025
How China and Indian Biotech are Teaming Up to Conquer the Global Mark...
2/14/2025
China Approves Novo Nordisk's Semaglutide Injection for New Indication
2/13/2025
Global PE Firms Compete to Acquire Majority Stake in Gland Pharma from...
2/11/2025
Novo Nordisk Reports Strong Growth in China for 2024, Driven by GLP-1 ...
1/28/2025
China's Evolving Role in Pharma Spurs Regional Realignments, Boosts In...
1/24/2025
Hengrui's Insulin Degludec BLA Accepted by China's NMPA
1/17/2025
Daiichi Sankyo Submits NDA for Pexidartinib (PLX3397) in China as the ...
1/13/2025
Hengruiand Kailera Report Positive Data from Phase 2 Obesity Trial of ...
Page:
1
/
42
Total number of articles:
1256
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit